Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 1
2009 5
2010 4
2011 5
2012 4
2013 3
2016 1
2017 2
2018 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

24 results
Results by year
Filters applied: . Clear all
Page 1
OX40 facilitates control of a persistent virus infection.
Boettler T, Moeckel F, Cheng Y, Heeg M, Salek-Ardakani S, Crotty S, Croft M, von Herrath MG. Boettler T, et al. PLoS Pathog. 2012 Sep;8(9):e1002913. doi: 10.1371/journal.ppat.1002913. Epub 2012 Sep 6. PLoS Pathog. 2012. PMID: 22969431 Free PMC article.
Vaccinia virus F1L protein promotes virulence by inhibiting inflammasome activation.
Gerlic M, Faustin B, Postigo A, Yu EC, Proell M, Gombosuren N, Krajewska M, Flynn R, Croft M, Way M, Satterthwait A, Liddington RC, Salek-Ardakani S, Matsuzawa S, Reed JC. Gerlic M, et al. Proc Natl Acad Sci U S A. 2013 May 7;110(19):7808-13. doi: 10.1073/pnas.1215995110. Epub 2013 Apr 19. Proc Natl Acad Sci U S A. 2013. PMID: 23603272 Free PMC article.
OX40 drives protective vaccinia virus-specific CD8 T cells.
Salek-Ardakani S, Moutaftsi M, Crotty S, Sette A, Croft M. Salek-Ardakani S, et al. J Immunol. 2008 Dec 1;181(11):7969-76. doi: 10.4049/jimmunol.181.11.7969. J Immunol. 2008. PMID: 19017988 Free PMC article.
24 results